Medindia LOGIN REGISTER
Medindia

Calcipotriene Interaction with other Drugs


Calcipotriene is a synthetic derivative of calcitriol or vitamin D, prescribed for plaque psoriasis.

Calcipotriene Interaction with 62 drugs. Find out more in the list below:

Acetyldigitoxin


Acetyldigitoxin may decrease the cardiotoxic activities of Calcipotriol.

Alfacalcidol


The risk or severity of adverse effects can be increased when Calcipotriol is combined with Alfacalcidol.

Aluminum Hydroxide


The serum concentration of Aluminum hydroxide can be increased when it is combined with Calcipotriol.

Advertisement

aluminum hydroxide, dried (USP)


The serum concentration of Aluminum hydroxide can be increased when it is combined with Calcipotriol.

Ancestim


The risk or severity of cytotoxicity can be increased when Ancestim is combined with Calcipotriol.

Bendroflumethiazide


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Bendroflumethiazide.

Advertisement

Benzthiazide


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Benzthiazide.

Bevacizumab


Bevacizumab may increase the cardiotoxic activities of Calcipotriol.

Bevacizumab-Awwb


Bevacizumab may increase the cardiotoxic activities of Calcipotriol.

Advertisement

Cabazitaxel


The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Calcipotriol.

Calcifediol


The risk or severity of adverse effects can be increased when Calcidiol is combined with Calcipotriol.

Calcifediol Anhydrous


The risk or severity of adverse effects can be increased when Calcidiol is combined with Calcipotriol.

Calcitriol


The risk or severity of adverse effects can be increased when Calcipotriol is combined with Calcitriol.

Calcium Acetate


The risk or severity of adverse effects can be increased when Calcium Acetate is combined with Calcipotriol.

Calcium Carbonate


The risk or severity of adverse effects can be increased when Calcium Carbonate is combined with Calcipotriol.

CALCIUM CARBONATE, PRECIPITATED


The risk or severity of adverse effects can be increased when Calcium Carbonate is combined with Calcipotriol.

Calcium Chloride


The risk or severity of adverse effects can be increased when Calcium Chloride is combined with Calcipotriol.

Calcium Chloride Anhydrous


The risk or severity of adverse effects can be increased when Calcium Chloride is combined with Calcipotriol.

Calcium Citrate


The risk or severity of adverse effects can be increased when Calcium Citrate is combined with Calcipotriol.

Calcium Glubionate


The risk or severity of adverse effects can be increased when Calcium glubionate is combined with Calcipotriol.

Calcium gluceptate


The risk or severity of adverse effects can be increased when Calcium Gluceptate is combined with Calcipotriol.

Calcium Gluconate


The risk or severity of adverse effects can be increased when Calcium gluconate is combined with Calcipotriol.

Calcium Lactate


The risk or severity of adverse effects can be increased when Calcium lactate is combined with Calcipotriol.

CALCIUM LEVULINATE


The risk or severity of adverse effects can be increased when Calcium levulinate is combined with Calcipotriol.

Casein Allergenic Extract


The risk or severity of adverse effects can be increased when Casein is combined with Calcipotriol.

Chlorothiazide


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Chlorothiazide.

Chlorthalidone


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Chlorthalidone.

Cholecalciferol


The risk or severity of adverse effects can be increased when Calcipotriol is combined with Cholecalciferol.

Cholestyramine Resin


The serum concentration of Calcipotriol can be decreased when it is combined with Cholestyramine.

Colesevelam


The serum concentration of Calcipotriol can be decreased when it is combined with Colesevelam.

Colestipol


The serum concentration of Calcipotriol can be decreased when it is combined with Colestipol.

Cyclopenthiazide


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Cyclopenthiazide.

Cyclophosphamide


Cyclophosphamide may increase the cardiotoxic activities of Calcipotriol.

Cyclophosphamide Anhydrous


Cyclophosphamide may increase the cardiotoxic activities of Calcipotriol.

Danazol


Danazol may increase the hypercalcemic activities of Calcipotriol.

Deslanoside


Deslanoside may decrease the cardiotoxic activities of Calcipotriol.

Digitoxin


Digitoxin may decrease the cardiotoxic activities of Calcipotriol.

Digoxin


Digoxin may decrease the cardiotoxic activities of Calcipotriol.

Dihydrotachysterol


The risk or severity of adverse effects can be increased when Dihydrotachysterol is combined with Calcipotriol.

Docetaxel


The risk or severity of adverse effects can be increased when Docetaxel is combined with Calcipotriol.

DOCETAXEL ANHYDROUS


The risk or severity of adverse effects can be increased when Docetaxel is combined with Calcipotriol.

Doxercalciferol


The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Calcipotriol.

Ergocalciferol


The risk or severity of adverse effects can be increased when Ergocalciferol is combined with Calcipotriol.

Heavy mineral oil


The serum concentration of Calcipotriol can be decreased when it is combined with Mineral oil.

Hydrochlorothiazide


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Hydrochlorothiazide.

Hydroflumethiazide


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Hydroflumethiazide.

Indapamide


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Indapamide.

Methyclothiazide


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Methyclothiazide.

Metolazone


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Metolazone.

Mineral Oil


The serum concentration of Calcipotriol can be decreased when it is combined with Mineral oil.

Orlistat


The serum concentration of Calcipotriol can be decreased when it is combined with Orlistat.

Ouabain


Ouabain may decrease the cardiotoxic activities of Calcipotriol.

Ovine Digoxin Immune Fab


Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Calcipotriol.

Paclitaxel


The risk or severity of adverse effects can be increased when Paclitaxel is combined with Calcipotriol.

Paricalcitol


The risk or severity of adverse effects can be increased when Paricalcitol is combined with Calcipotriol.

Polythiazide


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Polythiazide.

Proscillaridin


Proscillaridin may decrease the cardiotoxic activities of Calcipotriol.

Quinethazone


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Quinethazone.

Sucralfate


The serum concentration of Sucralfate can be increased when it is combined with Calcipotriol.

Trastuzumab


Trastuzumab may increase the cardiotoxic activities of Calcipotriol.

Tricalcium Phosphate


The risk or severity of adverse effects can be increased when Calcium Phosphate is combined with Calcipotriol.

Trichlormethiazide


The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Trichlormethiazide.

Advertisement
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Complete Hypertension Guide: Control, Causes and Prevention.
Stay Connected
Available on the Android Market Available on the App Store